Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Samuel B. Weidner"'
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 116-116 (2024)
OBJECTIVES/GOALS: Many economic evaluations rely on clinical trial data that may not represent real world populations and intervention effectiveness. We compare risk and cost-effectiveness for the Diabetes Prevention Program (DPP) clinical trial coho
Externí odkaz:
https://doaj.org/article/62028311ae274fb695b7351325404da5
Autor:
Tara A. Lavelle, Xue Feng, Marlena Keisler, Joshua T. Cohen, Peter J. Neumann, Daryl Prichard, Brock E. Schroeder, Daria Salyakina, Paula S. Espinal, Samuel B. Weidner, Jill L. Maron
Publikováno v:
Genetics in Medicine. 24:2415-2417
This study aimed to estimate the cost-effectiveness of exome sequencing (ES) and genome sequencing (GS) for children.We modeled costs, diagnoses, and quality-adjusted life years (QALYs) for diagnostic strategies for critically ill infants (aged1 year
Autor:
Tara A. Lavelle, Xue Feng, Marlena Keisler, Joshua T. Cohen, Peter J. Neumann, Daryl Prichard, Brock E. Schroeder, Daria Salyakina, Paula S. Espinal, Samuel B. Weidner, Jill L. Maron
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 24(12)
Autor:
Samuel B. Weidner, Joshua T. Cohen
Publikováno v:
F1000Research. 10:856
Background: In addition to reducing mortality and morbidity, COVID-19 therapies confer societal benefits by reducing the disease’s economic impact. Therapies that address COVID hospitalizations mitigate the need for government-imposed economic rest